TCL Archive Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives. March 26, 2004
TCL Archive ACR Defends Mammographic Exams For Women 35-40,Says Carcinogenic Threat Is “Small” July 30, 1976
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive NCI’s Problems With FDA Appear To Be Resolved With Agreement on Drug Distribution System August 26, 1977
